Fact CheckerSign in

NCT04140097Active, not recruiting

Predictors of Acute Exacerbation in Patients With COPD - an Observational Study

Predictors of Acute Exacerbation in Patients With COPD - an Observational Study (PACE Trial)

Source: ClinicalTrials.gov · Last updated 8 Nov 2024

Brief summary (registry, in English)

Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by respiratory problems and poor airflow with dyspnea and cough being the main symptoms. Acute exacerbations of COPD (AECOPD) are the most important events for patients with COPD that have a negative impact on patients´ quality of life, accelerate disease progression, and can result in hospital admissions and death. It is of major clinical importance to determine predictors of an AECOPD and to identify patients who are at high risk for developing an acute exacerbation and/or to detect the beginning of or prevent an ongoing acute exacerbation as early as possible. Until now, research in the field of AECOPD has gathered and analyzed data only after manifestation of AECOPD until recovery and most of them used a retrospective study design. Therefore, the aim of this prospective trial is to collect clinical data in patients prior to the first visible clinical signs of an AECOPD to investigate potential early predictors of an AECOPD.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
355 (actual)
First submitted
26 Sept 2019
Start date
26 Feb 2020
Primary completion date
30 Apr 2024
Lead sponsor
Schön Klinik Berchtesgadener Land
Diseases
COPD
NCT number
NCT04140097

What you commit to

  • Study type: Observational
  • Participants enrolled: 355
  • From 26 Feb 2020 to the primary completion date, 30 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \- current primary diagnosis of asthma

Who the study is looking for

  • confirmed diagnosis of Chronic Obstructive Pulmonary Disease according to Global Association for Obstructive Lung Disease stage II to IV
  • the ability to follow the rehabilitation protocol
  • provided written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Schoen Klinik Berchtesgadener Land
Coordinator of this site? Confirm its status
Schönau am KönigsseeGermanyUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.